A Case Report of A Life-Threatening Condition: Complete Heart Block Induced By Systemic Lupus Erythematosus
DOI:
https://doi.org/10.46799/jhs.v7i4.2824Keywords:
complete heart block, conduction block, myocarditis, pacemaker, systemic lupus erythematousAbstract
Systemic lupus erythematous is often accompanied by complications in the cardiovascular system such as pericarditis, valvular disease, coronary artery disease, but complications in the conduction pathway are rare condition. Conduction system disorders such as complete heart block can cause life-threatening conditions and require immediate treatment. This case report describes a 43-year-old woman who presented with syncope and complete heart block. The patient received high-dose corticosteroid therapy but the complete heart block did not improve so a permanent pacemaker was implanted. This case showed that SLE complications in the cardiovascular system including the cardiac conduction system must be watched out for because it is a life-threatening condition.
References
Bharati, S., De La Fuente, D. J., Kallen, R. J., Freij, Y., & Lev, M. (1975). Conduction system in systemic lupus erythematosus with atrioventricular block. The American Journal of Cardiology, 35(2), 299–304. https://doi.org/10.1016/0002-9149(75)90017-X
Buch, M. H., Mallat, Z., Dweck, M. R., Tarkin, J. M., O’Regan, D. P., Ferreira, V., Youngstein, T., & Plein, S. (2024). Current understanding and management of cardiovascular involvement in rheumatic immune-mediated inflammatory diseases. Nature Reviews Rheumatology, 20(10), 614–634.
Du Toit, R., Karamchand, S., Doubell, A. F., Reuter, H., & Herbst, P. G. (2023). Lupus myocarditis: Review of current diagnostic modalities and their application in clinical practice. Rheumatology, 62(2), 523–534. https://doi.org/10.1093/rheumatology/keac409
Fan, Z., Han, Y., Sun, G., & Dong, Z. (2025). Immunosuppressant adherence after heart transplantation: a review on detection, prevention, and intervention strategies in a multidisciplinary. Frontiers in Cardiovascular Medicine, 12, 1558082.
Gómez-Barrado, J. J., García-Rubira, J. C., Polo Ostáriz, M. A., & Turégano Albarrán, S. (2002). Complete atrioventricular block in a woman with systemic lupus erythematosus. International Journal of Cardiology, 82(3), 289–292. https://doi.org/10.1016/S0167-5273(01)00590-3
Jobling, K., Rajabally, H., & Ng, W.-F. (2018). Anti-Ro antibodies and complete heart block in adults with Sjögren’s syndrome. European Journal of Rheumatology, 5(3), 194–196. https://doi.org/10.5152/eurjrheum.2018.18019
Karnabi, E., & Boutjdir, M. (2010). Role of calcium channels in congenital heart block. Scandinavian Journal of Immunology, 72(3), 226–234. https://doi.org/10.1111/j.1365-3083.2010.02439.x
Lazzerini, P. E., Murthy Ginjupalli, V. K., Srivastava, U., et al. (2023). Anti-Ro/SSA antibodies blocking calcium channels as a potentially reversible cause of atrioventricular block in adults. JACC: Clinical Electrophysiology, 9(12), 1631–1648. https://doi.org/10.1016/j.jacep.2023.03.007
Lo, C. H., Wei, J. C. C., Tsai, C. F., Li, L. C., Huang, S. W., & Su, C. H. (2018). Syncope caused by complete heart block and ventricular arrhythmia as early manifestation of systemic lupus erythematosus in a pregnant patient: A case report. Lupus, 27(10), 1729–1731. https://doi.org/10.1177/0961203318782425
Maier, W. P., Ramirez, H. E., & Miller, S. B. (1987). Complete heart block as the initial manifestation of systemic lupus erythematosus. Archives of Internal Medicine, 147(1), 170–171. https://doi.org/10.1001/archinte.1987.00370010168034
Miner, J. J., & Kim, A. H. J. (2014). Cardiac manifestations of systemic lupus erythematosus. Rheumatic Disease Clinics of North America, 40(1), 51–60. https://doi.org/10.1016/j.rdc.2013.10.003
Mishra, V., Chatterjee, T., & M. C. (2023). Complete heart block: An atypical presentation with an atypical diagnosis. International Journal of Research in Medical Sciences, 11(10), 3855–3858. https://doi.org/10.18203/2320-6012.ijrms20233045
Mohanty, B., & Sunder, A. (2020). Lupus myocarditis: A rare case. Journal of Family Medicine and Primary Care, 9(8), 4441. https://doi.org/10.4103/jfmpc.jfmpc_716_20
Natsheh, A., Shimony, D., Bogot, N., Nesher, G., & Breuer, G. S. (2019). Complete heart block in lupus. Lupus, 28(13), 1589–1593. https://doi.org/10.1177/0961203319881198
Opałka, B., Żołnierczuk, M., & Grabowska, M. (2023). Immunosuppressive agents—effects on the cardiovascular system and selected metabolic aspects: a review. Journal of Clinical Medicine, 12(21), 6935.
Pan, S.-Y., Tian, H.-M., Zhu, Y., et al. (2022). Cardiac damage in autoimmune diseases: Target organ involvement that cannot be ignored. Frontiers in Immunology, 13, 1056400. https://doi.org/10.3389/fimmu.2022.1056400
Popescu, M. R., Dudu, A., Jurcut, C., Ciobanu, A. M., Zagrean, A.-M., & Panaitescu, A. M. (2020). A broader perspective on anti-Ro antibodies and their fetal consequences: A case report and literature review. Diagnostics, 10(7), 478. https://doi.org/10.3390/diagnostics10070478
Shariff, R., Lim, C., & Kasim, S. (2020). Complete heart block in a 40-year-old man with anti-SSA/Ro autoantibodies. Proceedings of Singapore Healthcare, 30(4). https://doi.org/10.1177/2010105820978668
Tana, C., Kouranos, V., Bernardinello, N., Mantini, C., Scarpa, R., Cinetto, F., Israël-Biet, D., & Spagnolo, P. (2025). Redefining cardiac sarcoidosis with advanced imaging and therapeutic strategies. American Journal of Cardiovascular Drugs, 1–22.
Tanwani, J., Tselios, K., Gladman, D. D., Su, J., & Urowitz, M. B. (2018). Lupus myocarditis: A single center experience and a comparative analysis of observational cohort studies. Lupus, 27(8), 1296–1302. https://doi.org/10.1177/0961203318770018
Wahren-Herlenius, M., & Sonesson, S.-E. (2006). Specificity and effector mechanisms of autoantibodies in congenital heart block. Current Opinion in Immunology, 18(6), 690–696. https://doi.org/10.1016/j.coi.2006.09.012
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Yogi Puji Rachmawan, Arsha Pramudya, Witri Pratiwi, Irnizarifka Irnizarifka, Fawzia Haznah Nurul Imani

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under aCreative Commons Attribution-ShareAlike 4.0 International (CC-BY-SA). that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.



